2. Yoshimura N. Topography of Pick body distribution in Pick's 23.
disease: a contribution to understanding the relationship between
Pick's and Alzheimer's diseases. Clin Neuropathol 1989;8:1– 6. 24.
3. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of
the preliminary NINDS neuropathologic criteria for progressive
supranuclear palsy and related disorders. J Neuropathol Exp 25.
Neurol 1996;55:97–105.
4. Constantinidis J, Richard J, Tissot R. Pick's disease: histological
and clinical correlations. Eur Neurol 1974;11:208 –217.
5. Dickson DW. Pick's disease: a modern approach. Brain Pathol 26.
1998;8:339 –354.
6. Probst A, Tolnay M, Langui, et al. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compart- 27.
ment. Acta Neuropathol 1996;92:588 –596.
7. Hof PR, Bouras C, Perl P, Morrison JH. Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution 28.
of Pick's bodies and coexistence with Alzheimer disease. Acta
Neuropathol 1994;87:115–124.
8. Esiri MM, Hyman BT, Beyreuther K, Masters CL. Ageing and 29.
dementia. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology. 6th ed. Vol 2. London: Arnold, 1997:153–233.
9. Glekman AM, Jiang Z, Liu Y, Smoth TW. Neuronal and glial 30.
DNA fragmentation in Pick's disease. Acta Neuropathol 1999;
98:55– 61.
10. Neary D. Frontotemporal degeneration, Pick's disease and cor- 31.
ticobasal degeneration: one entity or three? Arch Neurol 1997;
54:1425–1427.
11. Kertesz A. Frontotemporal degeneration, Pick's disease and cor- 32.
ticobasal degeneration: one entity or three? Arch Neurol 1997;
54:1427–1429.
12. Trojanowski JQT, Dickson D. Update on the neuropathologi- 33.
cal diagnosis of frontotemporal dementias. Ann Neurol 2001;
60:1123–1126.
13. Takauchi S, Hosomi M, Marasigan S, Sato M, et al. An ultrastructural study of Pick bodies. Acta Neuropathol 1984,64: 34.
344 –348.
14. Kato S, Nakamura H. Presence of two different fibril subtypes
in Pick bodies: an immunoelectron microscopic study. Acta 35.
Neuropathol 1990;81:125–129.
15. Love S, Burrola P, Terry RD, Wiley CA. Immunoelectron mi- croscopy of Alzheimer and Pick brain tissue labeled with the 36.
monoclonal antibody Alz 50. Neuropathol Appl Neurobiol
1989;15:223–231.
16. Murayama S, Mori H, Ihara Y, Tomonaga M. Immunocytochemical and ultrastructural studies of Pick's disease. Ann Neu- 37.
rol 1990;27:394 – 405.
17. King M, Ghoshal N, Wall JS, et al. Structural analysis of Pick's
disease-derived and in-vitro assembled tau filaments. Am J 38.
Pathol 2001;1584:1481–1490.
18. Hong M, Zhukareva V, Volksberg-Ragaglia V, et al. Mutationspecific functional impairments in distinct tau isoforms of he- 39.
reditary FTDP-17. Science 1998;82:1914 –1917.
19. Delacorte A, Robitaille Y, Sergeant N, et al. Specific pathological tau protein variants characterize Pick's disease. J Neuro- 40.
pathol Exp Neurol 1996;55:159 –168.
20. Delacorte A, Sergeant N, Wattez A, et al. Vulnerable neuronal
subsets in Alzheimer's and Pick's disease are distinguished by
their tau isoform distribution and phosphorylation. Ann Neurol 41.
1988;43:193–204.
21. Ishizawa K, Ksiezak-Reading H, Davies P, et al. A doublelabeling immunohistochemical study of tau exon 10 in Alzhei- 42.
mer disease, progressive supranuclear palsy and Pick's disease.
Acta Neuropathol 2000;100:235–244.
22. Arai T, Ikeda K, Akiyama H, et al. Distinct isoforms of tau 43.
aggregated in neurons and glial cells in brains of patients with
Pick's disease, corticobasal degeneration and progressive su- pranuclear palsy. Acta Neuropathol 2001;101:167–173.
